OBX — Obsidian Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Obsidian Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	71.2	31.6	18.3	8.29	6.38
Net Total Receivables	—	—	—	0.635	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	77.4	38.5	21.6	10	7.09
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.823	0.481	1.28	0	—
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	83.3	44	26.1	10.1	7.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	12.9	13.4	4.96	1.67	0.645
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	141	153	157	154	0.645
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-58	-109	-131	-144	6.55
Total Liabilities & Shareholders' Equity	83.3	44	26.1	10.1	7.2
Total Common Shares Outstanding
Total Preferred Shares Outstanding